Big Biopharma’s Mid-Life Crisis: One Analyst’s View of Amgen

Play Video

Big Biopharma's Midlife Crisis - Analyst Ted Cohan on Amgen

Bloomberg - (BLOOM)

Apr. 10, 2007. 08:34 PM EST

The company's begun to look like a big pharma company as it has grown. Baker Boyar Bancorp analyst Ted Cohan offered these brief comments to Bloomberg yesterday.